Antibiotics for acute maxillary sinusitis in adults

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 2, 2014, Pages

  Ahovuo Saloranta, Anneli ^a   Rautakorpi, Ulla Maija ^a   Borisenko, Oleg V ^b   Liira, Helena ^c   Williams, John W ^d   Mäkelä, Marjukka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Synergus AB   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEPHALOSPORIN; MACROLIDE; PENICILLIN DERIVATIVE; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT;

ACUTE SINUSITIS; ADULT; AMBULATORY CARE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIUM CULTURE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; FOLLOW UP; HUMAN; MAXILLA SINUSITIS; PATIENT ATTITUDE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SIDE EFFECT; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; ACUTE DISEASE; CLINICAL TRIAL (TOPIC); META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ACUTE DISEASE; ADULT; ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; MAXILLARY SINUSITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84907675418     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD000243.pub3     Document Type: Review

References (243)

1. Adelglass J, Jones TM, Ruoff G, Kahn JB, Wiesinger BA, Rielly-Gauvin K, et al.A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis. Pharmacotherapy 1998;18(6):1255-63.
2. Adelglass J, Bundy JM, Woods R. Efficacy and tolerability of cefprozil versus amoxicillin/clavulanate for the treatment of adults with severe sinusitis. Clinical Therapeutics 1998;20(6):1115-29. [MEDLINE: 99113644]
3. Adelglass J, DeAbate A, McElvaine P, Fowler CL, LoCocco J, Campbell T. Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults. Otolaryngology -Head and Neck Surgery 1999;120:320-7.
4. Arndt J, Riebenfeld D, Maier H, Weidauer H. Therapeutic efficacy and tolerability of brodimoprim in comparison with doxycycline in acute sinusitis in adults. Journal of Chemotherapy 1994;6(5):322-7. [MEDLINE: 95165185]
5. Arrieta JR, Galgano AS, Sakano E, Fonseca X, Amabile-Cuevas CF, Hernandez-Oliva G, et al.Moxifloxacin vs amoxicillin/clavulanate in the treatment of acute sinusitis. American Journal of Otolaryngology 2007;28(2):78-82.
6. Axelsson A, Chidekel N, Grebelius N, Jensen C. Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica (Stockholm) 1970;70(1):71-6. [MEDLINE: 70286389]
7. Boezeman AJ, Kayser AM, Siemelink RJ. Comparison of spiramycin and doxycycline in the empirical treatment of acute sinusitis: preliminary results. Journal of Antimicrobial Chemotherapy 1988;22(Suppl B):165-70. [MEDLINE: 89033421]
8. Buchanan PP, Stephens TA, Leroy B. A comparison of the efficacy of telithromycin versus cefuroxime axetil in the treatment of acute bacterial maxillary sinusitis. American Journal of Rhinology 2003;17(6):369-77.
9. Burke T, Villanueva C, Mariano H, Huck W, Orchard D, Haverstock D, et al.Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Clinical Therapeutics 1999;21(10):1664-77. [MEDLINE: 20030839]
10. Calhoun KH, Hokanson JA. Multicenter comparison of clarithromycin and amoxicillin in the treatment of acute maxillary sinusitis. Archives of Family Medicine 1993;2(8):837-40. [MEDLINE: 94154893]
11. Camacho AE, Cobo R, Otte J, Spector SL, Lerner CJ, Garrison NA, et al.Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis. American Journal of Medicine 1992;93(3):271-6. [MEDLINE: 92397909]
12. Chatzimanolis E, Marsan N, Lefatzis D, Pavlopoulos A. Comparison of roxithromycin with co-amoxiclav in patients with sinusitis. Journal of Antimicrobial Chemotherapy 1998;41(Suppl B):81-4. [MEDLINE: 98239321]
13. Clement PA, de Gandt JB. A comparison of the efficacy, tolerability and safety of azithromycin and co-amoxiclav in the treatment of sinusitis in adults. Journal of International Medical Research 1998;26(2):66-75. [MEDLINE: 98265694]
14. Clifford K, Huck W, Shan M, Tosiello R, Echols RM, Heyd A. Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group. Annals of Otology, Rhinology and Laryngology 1999;108(4):360-7. [MEDLINE: 99229596]
15. Desrosiers M, Ferguson B, Klossek JM, Drugeon H, Mösges R. Clinical efficacy and time to symptom resolution of 5-day telithromycin versus 10-day amoxicillin-clavulanate in the treatment of acute bacterial sinusitis. Current Medical Research and Opinion 2008;24(6):1691-702.
16. Dubois J, Saint-Pierre C, Tremblay C. Efficacy of clarithromycin vs. amoxicillin/clavulanate in the treatment of acute maxillary sinusitis. Ear, Nose and Throat Journal 1993;72(12):804-10. [MEDLINE: 94147948]
17. Ferguson BJ, Guzzetta RV, Spector SL, Hadley JA. Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis. Otolaryngology -Head and Neck Surgery 2004;131:207-14.
18. Garbutt J, Spitznagel E, Piccirillo J. Use of the modified SNOT-16 in primary care patients with clinically diagnosed acute rhinosinusitis. Archives of Otolaryngology -Head and Neck Surgery 2011;137(8):792-7.
19. Garbutt JM, Banister C, Spitznagel E, Piccirillo JF. Amoxicillin for acute rhinosinusitis: A randomized controlled trial. JAMA 2012;307(7):685-92.
20. Gehanno P, Barry B, Chauvin JP, Hazebroucq J. Clarithromycin versus amoxicillin/clavulanic acid in acute maxillary sinusitis in adults [Clarithromycine versus amoxicilline acide-clavulanique dans le traitement de la sinusite maxillaire aigue de l'adulte]. Pathologie Biologie (Paris) 1996;44(4):293-7. [MEDLINE: 96306077]
21. Gehanno P, Berche P, Sinusitis Study Group. Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Journal of Antimicrobial Chemotherapy 1996;37(Suppl A):105-14.
22. Gehanno P, Pessey JJ, Beauvillain De Montreuil C, Dubreuil C, Levy D, Berche P, et al.Cefatrizine versus amoxicillin-clavulanate in acute maxillary sinusitis in adults [Etude comparative de la cefatrizine et de l'amoxicilline-acide clavulanique dans le traitement des sinusites maxillaires aigues de l'acute]. Médecine et Maladies Infectieuses 1998;28:208-15.
23. Gehanno P, Berche P, Hercot O, d' Arras L, Cabrillac-Rives S, Derobert E, et al.Efficiency of a four-day course of pristinamycin compared to a five-day course of cefuroxime axetil for acute bacterial maxillary sinusitis in adult outpatients [Efficacite comparee de la pristinamycine en quatre jours et du cefuroxime axetil en cinq jours dans le traitement des sinusites maxillaires aigues bacteriennes de l'adulte]. Medecine et Maladies Infectieuses 2004;34:293-302.
24. Gwaltney JM Jr, Savolainen S, Rivas P, Schenk P, Scheld WM, Sydnor A, et al.Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group. Antimicrobial Agents and Chemotherapy 1997;41(7):1517-20. [MEDLINE: 97354383]
25. Hadley JA, Mösges R, Desrosiers M, Haverstock D, van Veenhuyzen D, Herman-Gnjidic Z. Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis. Laryngoscope 2010;120(5):1057-62.
26. Haye R, Lingaas E, Hoivik HO, Odegård T. Efficacy and safety of azithromycin versus phenoxymethylpenicillin in the treatment of acute maxillary sinusitis. European Journal of Clinical Microbiology and Infectious Diseases 1996;15(11):849-53. [MEDLINE: 97151573]
27. Haye R, Lingaas E, Hoivik HO, Odegård T. Azithromycin versus placebo in acute infectious rhinitis with clinical symptoms but without radiological signs of maxillary sinusitis. European Journal of Clinical Microbiology and Infectious Diseases 1998;17:309-12.
28. Henry DC, Riffer E, Sokol WN, Chaudry NI, Swanson RN. Randomized double-blind study comparing 3-and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis. Antimicrobial Agents and Chemotherapy 2003;47(9):2770-4.
29. Henry DC, Kapral D, Busman TA, Paris MM. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study. Clinical Therapeutics 2004;26(12):2026-33.
30. Huck W, Reed BD, Nielsen RW, Ferguson RT, Gray DW, Lund GK, et al.Cefaclor vs amoxicillin in the treatment of acute, recurrent, and chronic sinusitis. Archives of Family Medicine 1993;2(5):497-503. [MEDLINE: 94163345]
31. Jareoncharsri P, Bunnag C, Fooanant S, Tunsuriyawong P, Voraprayoon S, Srifuengfung S, et al.An open label, randomized comparative study of levofloxacin and amoxicillin/clavulanic acid in the treatment of purulent sinusitis in adult Thai patients. Rhinology 2004;42(1):23-9.
32. Karma P, Pukander J, Penttilä M, Ylikoski J, Savolainen S, Olen L, et al.The comparative efficacy and safety of clarithromycin and amoxycillin in the treatment of outpatients with acute maxillary sinusitis. Journal of Antimicrobial Chemotherapy 1991;27(Suppl A):83-90. [MEDLINE: 91216883]
33. Klapan I, Culig J, Oreskovic K, Matrapazovski M, Radosevic S. Azithromycin versus amoxicillin/clavulanate in the treatment of acute sinusitis. American Journal of Otolaryngology 1999;20(1):7-11. [MEDLINE: 99133606]
34. Lari AR, Ghaffariyeh A, Etesam N, Mostafavi H, Alaghehbandan R. A randomized controlled trial of 5-day regimen of azithromycin and a 10-day regimen of co-amoxiclav for treatment of acute sinusitis. Iranian Journal of Clinical Infectious Diseases 2010;5(3):137-41.
35. Lasko B, Lau CY, Saint-Pierre C, Reddington JL, Martel A, Anstey RJ. Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group. Journal of International Medical Research 1998;26(6):281-91. [MEDLINE: 99327309]
36. Lindbaek M, Hjortdahl P, Johnsen UL. Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ 1996;313(7053):325-9. [MEDLINE: 96343743]
37. Lindbaek M, Kaastad E, Dolvik S, Johnsen U, Laerum E, Hjortdahl P. Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut-off points in sinus CT. Rhinology 1998;36:7-11.
38. Luterman M, Tellier G, Lasko B, Leroy B. Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis. Ear, Nose & Throat Journal 2003;82(8):576-80, 582-4, 586 passim.
39. Marple BF, Roberts CS, Frytak JR, Schabert VF, Wegner JC, Bhattacharyya H, et al.Azithromycin extended release vs amoxicillin/clavulanate: symptom resolution in acute sinusitis. American Journal of Otolaryngology -Head and Neck Medicine and Surgery 2010;31(1):1-8.
40. Matthews BL, Suprax/Amoxicillin Clinical Sinusitis Study Team. Effectiveness and safety of cefixime and amoxicillin in adults with acute bacterial sinusitis. Managing Sinusitis: A Postgraduate Medicine Special Report 1997:41-9.
41. Mattucci KF, Levin WJ, Habib MA. Acute bacterial sinusitis. Minocycline vs amoxicillin. Archives of Otolaryngology -Head and Neck Surgery 1986;112(1):73-6. [MEDLINE: 86076561]
42. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology 2005;116:1289-95.
43. Meltzer EO, Gates D, Bachert C. Mometasone furoate nasal spray increases the number of minimal-symptom days in patients with acute rhinosinusitis. Annals of Allergy, Asthma & Immunology 2012;108:275-9.
44. Merenstein D, Whittaker C, Chadwell T, Wegner B, D'Amico F. Are antibiotics beneficial for patients with sinusitis complaints? A randomized double-blind clinical trial. Journal of Family Practice 2005;54(2):144-51.
45. Murray JJ, Emparanza P, Lesinskas E, Tawadrous M, Breen JD. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults. Otolaryngology -Head and Neck Surgery 2005;133:194-201.
46. Nyffenegger R, Riebenfeld D, Macciocchi A. Brodimoprim versus amoxicillin in the treatment of acute sinusitis. Clinical Therapeutics 1991;13(5):589-95. [MEDLINE: 92191253]
47. O'Doherty B. An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections. Journal of Antimicrobial Chemotherapy 1996;37(Suppl C):71-81. [MEDLINE: 96415941]
48. Olmo A, Sabater F, Broto J, Traserra J. Amoxicillin/clavulanic acid versus cefuroxime axetil in acute sinusitis [Amoxicilina-acido clavulanico y axetilo de cefuroxima en el tratamiento de la sinusitis aguda. Evaluacion clinica, radiologica y bacteriologica]. Acta Otorrinolaringologica Espanola 1994;45(1):25-9. [MEDLINE: 94263593]
49. Otte J, Viada JA, Buchi MD, Salgado O. Tratamiento de los procesos sinusales agudos del adulto con tetraciclina y una combinacion de sulfametopirazona-trimetoprim. Revista Medica de Chile 1983;111(11):1157-61. [MEDLINE: 84273842]
50. Pessey JJ, Dubreuil C, Gehanno P, Artaz MA, Scheimberg A. Four days cefixime, 10 days cefixime, or 10 days amoxicillin-clavulanate, for the treatment of acute sinusitis in adults [Efficacite et tolerance du cefuxime en traitement de 4 jour ou de 10 jours versus 10 jours d'amoxicilline-acide clavulanique dans les sinusites aigues de l'adulte]. Medecine et Maladies Infectieuses 1996;26(10):839-45.
51. Pessey JJ. Pristinamycin in the outpatient treatment of acute sinusitis in adults [Place de la pristinamycine dans le traitement des sinusites aigues de l'adulte en ville]. Presse Medicale 1999;28(Suppl 1):10-2. [MEDLINE: 99436765]
52. Pessey JJ, Gehanno P, Dabernat H. Pristinamycin versus cefuroxime axetil in the treatment of acute sinusitis in adults. Medicine et Maladies Infectieuses 2001;31(6):425-32.
53. Rakkar S, Roberts K, Towe BF, Flores SM, Heyd A, Warner J. Moxifloxacin versus amoxycillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience. International Journal of Clinical Practice 2001;55(5):309-15.
54. Riffer E, Spiller J, Palmer R, Shortridge V, Busman TA, Valdes J. Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: a randomized, investigator-blinded study. Current Medical Research and Opinion 2005;21(1):61-70.
55. Russell MD, Nolen T, Allen JM, Skuba K, De Regis RG, Nicaise C. Cefprozil versus amoxicillin/clavulanate in the treatment of acute, uncomplicated maxillary sinusitis in adults. A randomized, prospective clinical trial. Infections in Medicine 1997;14(Suppl):43-50. [MEDLINE: 1998004027]
56. Sher LD, McAdoo MA, Bettis RB, Turner MA, Li NF, Pierce PF. A multicenter, randomized, investigator-blinded study of 5-and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis. Clinical Therapeutics 2002;24(2):269-81.
57. Siegert R, Gehanno P, Nikolaidis P, Bagger-Sjöbäck D, Ibanez JM, Hampel B, et al.A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. Respiratory Medicine 2000;94:337-44. [MEDLINE: 20302041]
58. Siegert R, Berg O, Gehanno P, Leiberman A, Martinkenas JL, Nikolaidis P, et al.Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults. European Archives of Oto-Rhino-Laryngology 2003;260(4):186-94.
59. Scandinavian Study Group. Loracarbef versus doxycycline in the treatment of acute bacterial maxillary sinusitis. Journal of Antimicrobial Chemotherapy 1993;31(6):949-61. [MEDLINE: 93366716]
60. Stefansson P, Jacovides A, Jablonicky P, Sedani S, Staley H. Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis. Rhinology 1998;36(4):173-8. [MEDLINE: 99121815]
61. Sterkers O. Efficacy and tolerability of ceftibuten versus amoxicillin/clavulanate in the treatment of acute sinusitis. Chemotherapy 1997;43(5):352-7. [MEDLINE: 97454963]
62. Steurer M, Schenk P. Efficacy and safety of cefdinir in the treatment of maxillary sinusitis. European Archives of Otorhinolaryngology 2000;257:140-8. [MEDLINE: 20296297]
63. Nielsen RW. Acute bacterial maxillary sinusitis: results of U.S. and European comparative therapy trials [review]. American Journal of Medicine 1992;92(Suppl 6A):70-3. [MEDLINE: 92321191]
64. Sydnor TA Jr, Scheld WM, Gwaltney J Jr, Nielsen RW, Huck W, Therasse DG. Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitis. Ear, Nose and Throat Journal 1992;71(5):225-32. [MEDLINE: 92371213]
65. Upchurch J, Rosemore M, Tosiello R, Kowalsky S, Echols R. Randomized double-blind study comparing 7-and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis. Otolaryngology -Head and Neck Surgery 2006;135(4):511-7.
66. Van Buchem F, Knottnerus J, Schrijnemaekers V, Peeters M. No benefit of antibiotic treatment in acute maxillary sinusitis: a randomized double-blind placebo-controlled study. Nederlands Tijdschrift Voor Geneeskunde 1997;141(49):2405-11.
67. van Buchem FL, Knottnerus JA, Schrijnemaekers VJ, Peeters MF. Primary-care-based randomised placebo-controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet 1997;349(9053):683-7. [MEDLINE: 97232963]
68. von Sydow C, Savolainen S, Söderqvist A. Treatment of acute maxillary sinusitis-comparing cefpodoxime proxetil with amoxicillin. Scandinavian Journal of Infectious Diseases 1995;27(3):229-34. [MEDLINE: 96143362]
69. Agbim OG. A comparative study of doxycycline and ampicillin in the treatment of acute sinusitis. Chemotherapy 1975;21(Suppl 1):68-75.
70. Agbim OG. A comparative trial of doxycycline ('Vibramycin') and ampicillin in the treatment of acute sinusitis. Current Medical Research and Opinion 1974;2(5):291-4.
71. Alvart R. An open multicentre study to compare the efficacy and safety of sultamicillin with that of cefuroxime axetil in acute ear nose and throat infections in adults. Journal of International Medical Research 1992;20(Suppl 1):53A-61A.
72. Axelsson A, Chidekel N, Grebelius N, Jensen C, Särne S. Treatment of acute maxillary sinusitis. II. A comparison of five further methods. Acta Otolaryngologica (Stockholm) 1971;72(1):148-54.
73. Axelsson A, Chidekel N, Jensen C, Grebelius N, Singer F. Treatment of acute maxillary sinusitis. Doxycycline and spiramycin with and without irrigation. Annals of Otology, Rhinology and Laryngology 1973;82(2):186-91.
74. Axelsson A, Grebelius N, Jensen C, Melin O, Singer F. Treatment of acute maxillary sinusitis. IV. Ampicillin, cephradine and erythromycinestolate with and without irrigation. Acta Otolaryngologica (Stockholm) 1975;79(5-6):466-72.
75. Axelsson A, Jensen C, Melin O, Singer F, von Sydow C. Treatment of acute maxillary sinusitis. V. Amoxicillin, azidocillin, phenylpropanolamine and pivampicillin. Acta Otolaryngologica (Stockholm) 1981;91(3-4):313-8.
76. Bandak S, Bolzon L, Johns D, Henle S, Allen B. Cefaclor advanced formulation 750mg twice daily versus clarithromycin 500mg twice daily in the treatment of acute maxillary sinusitis. Current Therapeutic Research 1999;60(4):185-94.
77. Beatson JM, Marsh BT, Talbot DJ. A clinical comparison of pivmecillinam plus pivampicillin (Miraxid) and a triple tetracycline combination (Deteclo) in respiratory infections treated in general practice. Journal of International Medical Research 1985;13(4):197-202.
78. Bockmeyer M, Riebenfeld D, Clasen B. Controlled study of brodimoprim and cephalexin in the treatment of patients with acute sinusitis in general practice. Clinical Therapeutics 1994;16(4):653-61.
79. Brodie DP, Knight S, Cunningham K. Comparative study of cefuroxime axetil and amoxicillin in the treatment of acute sinusitis in general practice. Journal of International Medical Research 1989;17(6):547-51.
80. Brook I, Hausfeld JN. Effect of telithromycin and azithromycin on nasopharyngeal bacterial flora in patients with acute maxillary sinusitis. Archives of Otolaryngology -Head & Neck Surgery 2006;132(4):442-5.
81. Bucher HC, Tschudi P, Young J, Periat P, Welge-Luussen A, Zust H, et al.Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice. Archives of Internal Medicine 2003;163(15):1793-8.
82. Carenfelt C, Eneroth CM, Lundberg C, Wretlind B. Evaluation of the antibiotic effect of treatment of maxillary sinusitis. Scandinavian Journal of Infectious Diseases 1975;7(4):259-64.
83. Casiano RR. Azithromycin and amoxicillin in the treatment of acute maxillary sinusitis. American Journal of Medicine 1991;91(Suppl 3A):27-30.
84. Correa A, Hernandez C. Estudio comparativo de la asociacion trimetoprim -sulfametopirazina y amoxocilina en sinusitis maxilar aguda. Revista Medica de Chile 1986;114(3):215-20.
85. De Abate CA, Perrotta RJ, Dennington ML, Ziering RM. The efficacy and safety of once-daily ceftibuten compared with co-amoxiclav in the treatment of acute bacterial sinusitis. Journal of Chemotherapy 1992;4(6):358-63.
86. De Sutter A, Lemiengre M, Van Maele G, van Driel M, De Meyere M, Christiaens T, et al.Predicting prognosis and effect of antibiotic treatment in rhinosinusitis. Annals of Family Medicine 2006;4(6):486-93.
87. De Sutter AI, De Meyere MJ, Christiaens TC, Van Driel ML, Peersman W, De Maeseneer JM. Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double-blind controlled trial in family practice. Journal of Family Practice 2002;51(4):317-23.
88. Edelstein DR, Avner SE, Chow JM, Duerksen RL, Johnson J, Ronis M, et al.Once-a-day therapy for sinusitis: a comparison study of cefixime and amoxicillin. Laryngoscope 1993;103(1 Pt 1):33-41.
89. Ekedahl C. [Akute Sinusitis bei Erwachsenen]. Infection 1987;15(Suppl 3):120-2.
90. Elies W. Short course therapy with cefuroxime axetil for five days in comparison to ten days of therapy with clarithromycin in acute sinusitis [Kurzzeittherapie mit cefuroximaxetil uber funf tage im vergleich zur zehn-tage-therapie mit clarithromycin bei akuter sinusitis]. Chemotherapie Journal 2001;10(3):105-9.
91. Falser N, Mittermayer H, Weuta H. Antibacterial treatment of otitis and sinusitis with ciprofloxacin and penicillin V. A comparison. Infection 1988;16(Suppl 1):51-4.
92. Federspil P, Koch J. Double-blind comparative trial of trimethoprim/sulfamethopyrazine once daily vs erythromycin 4 x daily in patients with ENT infections. International Journal of Clinical Pharmacology, Therapy, and Toxicology 1983;21(10):535-9.
93. Felstead SJ, Daniel R. Short-course treatment of sinusitis and other upper respiratory tract infections with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group. Journal of International Medical Research 1991;19(5):363-72.
94. Fiscella RG, Chow JM. Cefixime for treatment of maxillary sinusitis. American Journal of Rhinology 1991;5(5):193-7.
95. Freche C, Fombeur JP, Pappo M. Evaluation du cefuroxime-axetil dans le traitement des sinusites aigues de l'adulte. Etude comparative avec le cefaclor. Therapie 1988;43(Suppl 4):365-8.
96. Gananca M, Trabulsi LR. The therapeutic effects of cyclacillin in acute sinusitis: in vitro and in vivo correlations in a placebo-controlled study. Current Medical Research and Opinion 1973;1(6):362-8.
97. Gananca M, Gasel J. A double-blind study with the association tetracycline, acetylsalicylic acid, phenacetin, caffeine and phenyltoloxamine in the treatment of acute sinusitis. Folha Medica 1977;75(5):583-5.
98. Garcia C, Velert V, Orts A, Pardo M, Esparcia N. Comparison of azithromycin, amoxicillin/clavulanic acid and cefaclor in the treatment of acute ENT infections [Comparacion de azithromicina, amoxicilina/acido clavulanico y cefaclor en el tratamiento de la infeccion aguda otorrinolaringologica]. Acta Otorrinolaringologica Espanola 1998;49(4):306-12.
99. Gladkov AA, Andrijchuk AI, Neporada VP. Sravnitel'naia effektivnost' lecheniia bol'nykh ostrym i khronicheskim gnoinym vospaleniem verkhnecheliustnoi pazukhi rastvorami dekametoksina, formal'degida i penitsillina. Zhurnal Ushnykh, Nosovykh i Gorlovykh Boleznei 1979;3:21-5.
100. Goumas P, Naxakis S, Bassaris C, Skoutelis A. Comparative efficacy and tolerability of clarithromycin and cefaclor in the treatment of outpatients with acute maxillary sinusitis. Clinical Drug Investigation 1997;13(3):128-33.
101. Gurdogan K, Senol E. Comparison of 3-day course of azithromycin with penicillin V and amoxicillin+clavulanate in the treatment of upper respiratory tract infections [Ust solunum yolu enfeksiyonlarinin tedavisinde uc gun sureli azitromisin ile penisilin V ve amoksisilin+klavulonatin karsilastirilmasi]. Mikrobiyoloji Bulteni 2001;35(2):239-43.
102. Gwaltney JM Jr, Sydnor A Jr, Sande MA. Etiology and antimicrobial treatment of acute sinusitis. Annals of Otology, Rhinology and Laryngology 1981;90(Suppl 84):68-71.
103. Hamory BH, Sande MA, Sydnor A Jr, Seale DL, Gwaltney JM Jr. Etiology and antimicrobial therapy of acute maxillary sinusitis. Journal of Infectious Diseases 1979;139(2):197-202.
104. Hansen J, Schmidt H, Grinsted P. [Penicillinbehandling af akut kaebehulebetaendelse hos voksne]. Ugeskrift for Laeger 2000;162(40):5351-3.
105. Hansen JG, Schmidt H, Grinsted P. Randomised, double blind, placebo controlled trial of penicillin V in the treatment of acute maxillary sinusitis in adults in general practice. Scandinavian Journal of Primary Health Care 2000;18:44-7. [MEDLINE: 20269180]
106. Hebblethwaite EM, Brown GW, Cox DM. A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infections. Drugs Under Experimental and Clinical Research 1987;13(2):91-4.
107. Henry DC, Moller DJ, Adelglass J, Scheld WM, Jablonski CK, Zhang H, et al.Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group. Clinical Therapeutics 1999;21(2):340-52.
108. Henry DC, Sydnor A Jr, Settipane GA, Allen J, Burroughs S, Cobb MM, et al.Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis. Clinical Therapeutics 1999;21(7):1158-70.
109. Husfeldt P, Egede F, Nielsen PB. Antibiotic treatment of sinusitis in general practice. A double-blind study comparing ofloxacin and erythromycin. European Archives of Otorhinolaryngology 1993;250(Suppl 1):S23-5.
110. Jeppesen F, Schaldemose HJ. Doxycycline (Vibramycin) in the treatment of sinusitis [Doxycyclinum (Vibramycin) i behandlingen af sinuitis]. Ugeskrift for Laeger 1970;132:437-43.
111. Johnson PA, Rodriquez HP, Wazen JJ, Huck W, Shan M, Tosiello R, et al.Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group. Journal of Otolaryngology 1999;28(1):3-12.
112. Karpov OI. The clinical and economic efficacies of short courses of azithromycin in acute sinusitis. Antibiotiki i Khimioterapiia 1999;44(10):28-32.
113. Karpov OI, Riabova MA, Karpishchenko SA, Zaitseva AA. Comparative trial of 3-day azithromycin versus 10-day coamoxilav course efficacy in acute sinusitis. Terapevticheskii Arkhiv 1998;70(5):72-6.
114. Klein GL, Whalen E, Echols RM, Heyd A. Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis. Journal of Otolaryngology 1998;27(1):10-6.
115. Kaiser L, Morabia A, Stalder H, Ricchetti A, Auckenthaler R, Terrier F, et al.Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology & infectious Diseases 2001;20(7):445-51.
116. Lacroix JS, Ricchetti A, Lew D, Delhumeau C, Morabia A, Stalder H, et al.Symptoms and clinical and radiological signs predicting the presence of pathogenic bacteria in acute rhinosinusitis. Acta Oto-Laryngologica 2002;122(2):192-6.
117. Li XP, Qin ZM, Zheng RH, Tan QL, Zhou YY, Zhu L, et al.Comparison of the effectiveness of levofloxacin and cefuroxime for the treatment of sinusitis. Lin Chuang Erh Pi Yen Hou Ko Tsa Chih (Journal of Clinical Otorhinolaryngology) 2000;14(12):573-5.
118. Lopez Rubio A, Estrada Velasco A, Ibarra J, Lazos O. [Antibioticoterapia de espectro intermedio en infecciones O.R.L]. Prensa Medica Mexicana 1975;40(7-8):256-8.
119. Luchikhin LA, Troitskii SA. Etiotropic therapy with sparfioxamine in ENT practice. Vestnik Otorinolaringologii 2005;6:43-5.
120. Mannhardt J, Held J. Eine randomisierte Vergleichsstudie der therapeutischen Wirkung von amoxicillin und doxycyclin bei Sinusitis. Therapiewoche 1980;30:2087-9.
121. Manzini M, Caroggio A. Efficacy and tolerability of brodimoprim and roxithromycin in acute sinusitis of bacterial origin in adults. Journal of Chemotherapy 1993;5(6):521-5.
122. Marchi E. Comparative efficacy and tolerability of clarithromycin and amoxycillin in the treatment of out-patients with acute maxillary sinusitis. Current Medical Research and Opinion 1990;12(1):19-24.
123. Marcolino FMD, Ferracini NW, Gobbato LH, Hernandes MAR. Open comparative study of the efficacy and tolerability of azithromycin versus amoxycillin in the treatment of acute rhinosinusitis [Estudo comparativo e aberto sobre a eficacia e a tolerabilidade da azithromicina vs amoxicilina em rinossinusites agudas em adultos]. Revista Brasileira de Medicina 1999;56(4):294-8.
124. Mesure R. [Essai en double aveugle de l'association de sulfamethoxazole et de trimethoprime dans les infections oto-rhino-laryngologiques]. Acta Otorhinolaryngologica Belgica 1973;27(1):27-33.
125. Mira E, Benazzo M. A multicenter study on the clinical efficacy and safety of roxithromycin in the treatment of ear-nose-throat infections: comparison with amoxycillin/clavulanic acid. Journal of Chemotherapy 2001;13(6):621-7.
126. Miyamoto N, Murakami S, Watanabe N, Ozeki M. Bacteriological and clinical evaluation of azithromycin and cefcapene-pivoxil in otorhinolaryngological infections. Japanese Journal of Chemotherapy 2005;53(7):417-20.
127. Moorhouse EC, Hickey MP, O'Hanrahan MT, Clarke PC. General practice studies with combined pivampicillin/pivmecillinam (Miraxid). Irish Medical Journal 1985;78(11):314-7.
128. Norrelund N. [Behandling af sinusitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger 1978;140(45):2792-5.
129. Olsson O, Henning C. Clinical study on bacampicillin in otitis media acuta and sinusitis acuta. Penicillins and cephalosporins. In: Williams JD, Geddes AM editor(s). Chemotherapy. Vol. 5, New York: Plenum Press, 1976:145-50.
130. Osman MF, Menday AP. Single-blind comparison of miraxid and co-trimoxazole in patients with sinusitis and otitis. Proceedings of the 13th International Congress of Chemotherapy. Vienna, 1983; Vol. 1, issue 1-5:26-9.
131. Pallestrini E, Cimino A, Colletti V, Conticello S, De Campora E, De Martini E, et al.[Rufloxacina in confronto a claritromicina nel trattamento short-term delle patologie infettive di interesse otorinolaringoiatrico]. Rivista Italiana di Otorinolaringologia, Audiologia e Foniatria 1995;15(3):236-45.
132. Panosetti E. Phlegmonous and abscess-forming ENT infections: comparative efficacy of ceftriaxone versus amoxicillin-clavulanic acid. ORL -Journal for Oto-Rhino-Laryngology and its Related Specialties 1992;54(2):95-9.
133. Peyramond D, Abenhaim N, Chiche D. Community acquired respiratory infections: cefuroxime axetil versus amoxicillin/clavulanic acid [Etude du traitement antibiotique des infections respiratoires acquises en ville: cefuroxime axetil vs amoxicilline/acide clavulanique]. Medecine et Maladies Infectieuses 1991;21(Special Issue):98-102.
134. Piragine F, Sellari-Franceschini S, Berrettini S, Bruschini P, Grossi P. Amoxicillin-clavulanic acid combination in ORL infection with a proven bacterial etiology. Rivista Italiana di Otorinolaringologia, Audiologia e Foniatria 1988;8(4):321-5.
135. Podvinec M. [Co-tetroxazin (Tibirox) und Doxycyclin (Vibramycin) in der Behandlung von Infekten der Oberen Luftwege: eine Doppelblindstudie]. Therapeutische Umschau 1982;39(10):815-20.
136. Polonovski JM, El Mellah M. Treatment of acute maxillary sinusitis in adults. Comparison of cefpodoxime-proxetil and amoxicillin-clavulanic acid. Presse Medicale 2006;35(1 Pt 1):33-8.
137. Quick CA, Wagner D. Trimethoprim-sulfamethoxazole in the treatment of infections of the ears, nose and throat. Journal of Infectious Diseases 1973;128(Suppl):696-700.
138. Quick CA. Comparison of penicillin and trimethoprim-sulfamethoxazole in the treatment of ear, nose and throat infections. Canadian Medical Association Journal 1975;112(13 Spec No):83-6.
139. Rantanen T, Arvilommi H. Double-blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica (Stockholm) 1973;76(1):58-62.
140. Rechtweg J, Moinuddin R, Houser S, Mamikoglu B, Corey J. Quality of life in treatment of acute rhinosinusitis with clarithromycin and amoxicillin/clavulanate. Laryngoscope 2004;114(5):806-10.
141. Riedel H, Schmidt A, Upmeyer HJ. Is supplementary antibiotic treatment of sinusitis advantageous?. Therapiewoche 1987;37:4189-97.
142. Rimmer D, Suprax/Amoxicillin Clinical Study Team. Efficacy of cefixime and amoxicillin in adults with acute sinusitis. A Special Report. Sinusitis: optimizing management strategies. Postgraduate Medicine 1998:50-7.
143. Roenning Arnesen A, Spada L. Double-blind comparison of spiramycin and phenoxymethylpenicillin in treatment of upper respiratory tract infections (tonsillitis and rhinosinusitis). Chemioterapia 1987;6(Suppl 2):451-2.
144. Sabater F, Larrosa F, Guiroa M, Ciges M, Figuerola A, Fernandez F. Cefpodoxime proxetil (5 days) vs amoxicillin/clavulanic acid (8 days) in the treatment of acute maxillar-ethmoidal sinusitis in adult outpatients. Canadian Journal of Infectious Diseases 1995;6(Suppl C):Abstract 3100.
145. Salmi HA, Lehtomäki K, Kylmämaa T. Comparison of brodimoprim and doxycycline in acute respiratory tract infections. A double-blind clinical trial. Drugs Under Experimental and Clinical Research 1986;12(4):349-53.
146. Salmi HA. Brodimoprim in acute respiratory tract infections. Journal of Chemotherapy 1993;5(6):532-6.
147. Schering-Plough Research Institute. Efficacy and safety of 200 mcg QD or 200 mcg BID mometasone fuorate (MFNS) vs. amoxicillin vs. placebo as primary treatment of subjects with acute rhinosinusitis (Protocol P02692). Kenilworth: Schering-Plough Research Institute 2003.
148. Serra A, Schito GC, Nicoletti G, Fadda G. A therapeutic approach in the treatment of infections of the upper airways: thiamphenicol glycinate acetylcysteinate in sequential treatment (systemic-inhalatory route). International Journal of Immunopathology and Pharmacology 2007;20(3):607-17.
149. Söderström M, Blomberg J, Christensen P, Hovelius B. Erythromycin and phenoxymethylpenicillin (penicillin V) in the treatment of respiratory tract infections as related to microbiological findings and serum C-reactive protein. Scandinavian Journal of Infectious Diseases 1991;23(3):347-54.
150. Spindler JJ, Marsh BT, Talbot DJ. Respiratory infections in general practice. A clinical comparison of pivmecillinam-plus-pivampicillin (Miraxid) and cephalexin (Ceporex). Clinical Trials Journal 1985;22(4):293-9.
151. Stahl JP, Pappo M. A multicenter randomized trial of cefuroxime-axetil versus amoxicillin with clavulanic acid in community-acquired ENT and lower respiratory tract infections [Etude comparative du cefuroxime-axetil versus l'association d'amoxicilline et d'acide clavulanique dans les infections ORL et bronchiques]. Semaine des Hopitaux 1989;65(5):247-51.
152. Stalman W, van Essen GA, van der Graaf Y, de Melker RA. The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? A placebo-controlled double-blind randomized doxycycline trial. British Journal of General Practice 1997;47(425):794-9.
153. Strachunskii LS, Tikhonov VG, Kuleshov SE, Asmolovski VM. [Sravnitel'naia klinicheskaia effektivenost' i perenosimost' azitromitsina (sumamded) i eritromitsina u bol'nykh s sinusitami]. Antibiotiki i Khimioterapiia 1993;38(1):13-6.
154. Sydnor A Jr, Gwaltney JM Jr, Cocchetto DM, Scheld WM. Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis. Archives of Otolaryngology -Head and Neck Surgery 1989;115(12):1430-3.
155. Taub SJ. The use of bromelains in sinusitis: a double-blind clinical evaluation. Eye, Ear, Nose and Throat Monthly 1967;46(3):361-5.
156. Varonen H, Kunnamo I, Savolainen S, Mäkelä M, Revonta M, Ruotsalainen J, et al.Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo-controlled randomised trial. Scandinavian Journal of Primary Health Care 2003;21:121-6.
157. von Sydow C, Axelsson A, Jensen C. Treatment of acute maxillary sinusitis. Erythromycin base and phenoxymethyl-penicillin (penicillin V). Rhinology 1984;22(4):247-54.
158. Wallace RB, Marsh BT, Talbot DJ. A multi-centre general practice clinical evaluation of pivmecillinam plus pivampicillin ('Miraxid') and co-trimoxazole ('Septrin') in respiratory tract infections. Current Medical Research and Opinion 1985;9(10):659-65.
159. Weis M, Hendrick K, Tillotson G, Gravelle K, Rhinosinusitis Investigation Group. Multicenter comparative trial of ciprofloxacin versus cefuroxime axetil in the treatment of acute rhinosinusitis in a primary care setting. Clinical Therapeutics 1998;20(5):921-32.
160. Westerman T, Panzer JD, Atkinson WH. Comparative efficacy of clindamycin HC1 and tetracycline HCl in acute sinusitis. Eye, Ear and Nose Monthly 1975;54(6):236-8.
161. Williamson IG, Rumsby K, Benge S, Moore M, Smith PW, Cross M, et al.Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis. JAMA 2007;298(21):2487-96.
162. Young J, Bucher H, Tschudi P, Periat P, Hugenschmidt C, Welge-Lussen A. The clinical diagnosis of acute bacterial rhinosinusitis in general practice and its therapeutic consequences. Journal of Clinical Epidemiology 2003;56:377-84.
163. Young J, Tschudi P, Periat P, Hugenschmidt C, Welge-Lussen A, Bucher HC. Patients' expectations about the benefit of antibiotic treatment: lessons from a randomised controlled trial. Forschende Komplementärmedizin und Klassische Naturheilkunde 2005;12:347-9.
164. Zbären P, Pradervand M. [Etude clinique comparative en double aveugle entre co-tetroxacine et amoxicilline dans les infections ORL courantes]. Schweizerische Rundschau fur Medizin Praxis 1983;72(47):1491-3.
165. Ah-See KW, Evans AS. Sinusitis and its management. BMJ 2007;334:358-61.
166. Albrich WC, Monnet DL, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerging Infectious Diseases 2004;10(3):514-7.
167. Andre M, Odenholt I, Schwan Å, The Swedish Study Group on Antibiotic Use. Upper respiratory tract infections in general practice: diagnosis, antibiotic prescribing, duration of symptoms and use of diagnostic tests. Scandinavian Journal of Infectious Diseases 2002;34(12):880-6.
168. Arason VA, Kristinsson KG, Sigurdsson JA, Stefansdottir G, Mölstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 1996;313:387-91.
169. Arason VA, Sigurdsson JA, Kristinsson KG, Getz L, Gudmundsson S. Otitis media, tympanostomy tube placement, and use of antibiotics. Scandinavian Journal of Primary Health Care 2005;23(3):184-91.
170. Axelsson A, Chidekel N. Symptomatology and bacteriology correlated to radiological findings in acute maxillary sinusitis. Acta Otolaryngologica 1972;74:118-22.
171. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003;289(4):454-65.
172. Benninger MS, Sedory Holzer SE, Lau J. Diagnosis and treatment of uncomplicated acute bacterial rhinosinusitis: Summary of the Agency for Health Care Policy and Research evidence-based report. Otolaryngology -Head and Neck Surgery 2000;122(1):1-7.
173. Berg O, Carenfelt C, Rystedt G, Änggård A. Occurrence of asymptomatic sinusitis in common cold and other acute ENT-infections. Rhinology 1986;24:223-5.
174. Bhandari M, Busse JW, Jackowski D, Montori VM, Schunemann H, Spraque S, et al.Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Canadian Medical Association Journal 2004;170(4):477-80.
175. Bronzwaer SL, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, et al.A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerging Infectious Diseases 2002;8(3):278-82.
176. Chokkalingam A, Scherer R, Dickersin K. Agreement of data in abstracts compared to full publications. Controlled Clinical Trials 1998;19(Suppl):61-2.
177. de Bock GH, Dekker FW, Stolk J, Springer MP, Kievit J, van Houwelingen JC. Antimicrobial treatment in acute maxillary sinusitis: a meta-analysis. Journal of Clinical Epidemiology 1997;50(8):881-90.
178. de Ferranti SD, Ioannidis JPA, Lau J, Anninger WV, Barza M. Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis. BMJ 1998;317:632-7.
179. The European Antimicrobial Resistance Surveillance System. EARSS interactive database. http://www.rivm.nl/earss/database (accessed August 2010).
180. European Commission on Radiation Protection 118. Referral guidelines for imaging. http://ec.europa.eu/energy/nuclear/radioprotection/publication/doc/118_en.pdf (accessed June 2010).
181. Falagas ME, Giannopoulou KP, Vardakas KZ, Dimopoulos G, Karageorgopoulos DE. Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomised controlled trials. Lancet Infectious Diseases 2008;8:543-52.
182. Falagas ME, Karageorgopoulos DE, Grammatikos AP, Matthaiou DK. Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta-analysis of randomized trials. British Journal of Clinical Pharmacology 2008;67(2):161-71.
183. Fokkens WJ, Lund VJ, Mullol J, on behalf of the European Position Paper on Rhinosinusitis and Nasal Polyps group. European Position Paper on Rhinosinusitis and Nasal Polyps. Rhinology 2007;45(Suppl 20):1-139.
184. Goossens H, Ferech M, Vander Stichele R, Elseviers M, for the ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-87.
185. Brozek J, Oxman A, Schünemann H. GRADEpro Version 3.2 for Windows. 2008.
186. Guillemot D, Carbon C, Balkau B, Geslin P, Lecoeur H, Vauzelle-Kervroedan F, et al.Low dosage and long treatment duration of ß-lactam. Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998;279(5):365-70.
187. Gwaltney JM Jr, Scheld WM, Sande MA, Sydnor A. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. Journal of Allergy and Clinical Immunology 1992;90:457-62.
188. Gwaltney JM Jr, Phillips CD, Miller RD, Riker DK. Computed tomographic study of the common cold. New England Journal of Medicine 1994;330(1):25-30.
189. Gwaltney JM Jr. Acute community-acquired sinusitis. Clinical Infectious Diseases 1996;23:1209-25.
190. Gwaltney JM Jr, Wiesinger BA, Patrie JT. Acute community-acquired bacterial sinusitis: the value of antimicrobial treatment and the natural history. Clinical Infectious Diseases 2004;38:227-33.
191. Gwaltney JM Jr. Sinusitis. In: Mandell GL, Bennett JE, Dolin R editor(s). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Philadelphia: Elsevier, 2005:772-83.
192. Hansen FS, Hoffmans R, Georgalas C, Fokkens WJ. Complications of acute rhinosinusitis in The Netherlands. Family Practice 2012;29(2):147-53.
193. Hay AD, Thomas M, Montgomery A, Wetherell M, Lovering A, McNulty C, et al.The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient data. Journal of Antimicrobial Chemotherapy 2005;56(1):146-53.
194. Hickner JM, Bartlett JG, Besser RE, Gonzales R, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Annals of Internal Medicine 2001;134:498-505.
195. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
196. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org. 5.1. Chichester, UK: Wiley-Blackwell, 2011.
197. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org. 5.1. Chichester, UK: Wiley-Blackwell, 2011.
198. Hopewell S, Clarke M, Askie L. Reporting of trials presented in conference abstracts needs to be improved. Journal of Clinical Epidemiology 2006;59:681-4.
199. Howard JE, Nelson JD, Clahsen J, Jackson LH. Otitis media of infancy and early childhood. A double-blind study of four treatment regimens. American Journal of Diseases of Children 1976;130(9):965-70.
200. Hsin CH, Su MC, Tsao CH, Chuang CY, Liu CM. Bacteriology and antimicrobial susceptibility of pediatric chronic rhinosinusitis: a 6-year result of maxillary sinus punctures. American Journal of Otolaryngology 2010;31(3):145-9.
201. International Classification of Diseases (ICD-10). http://apps.who.int/classifications/apps/icd/icd10online/ 2010 (accessed September 2010).
202. Ioannidis JPA, Contopoulos-Ioannidis DG, Chew P, Lau J. Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections. Journal of Antimicrobial Chemotherapy 2001;48:677-89.
203. Ioannidis JPA, Chew P, Lau J. Standardized retrieval of side effects data for meta-analysis of safety outcomes. A feasibility study in acute sinusitis. Journal of Clinical Epidemiology 2002;55(6):619-26.
204. Ip S, Fu L, Balk E, Chew P, DeVine D, Lau J. Update on acute bacterial rhinosinusitis. Evidence Report/Technology Assessment No. 124. AHRQ Publication No. 05-E020-2. Rockville, MD: Agency for Healthcare Research and Quality 2005. [Prepared by Tufts-New England Medical Center Evidence-based Practice Center under Contract No. 290-02-0022]
205. Joki-Erkkilä VP, Pukander J, Laippala P. Alteration of clinical picture and treatment of pediatric acute otitis media over the past two decades. International Journal of Pediatric Otorhinolaryngology 2000;55(3):197-201.
206. Jousimies-Somer HR, Savolainen S, Ylikoski JS. Bacteriological findings of acute maxillary sinusitis in young adults. Journal of Clinical Microbiology 1988;26(10):1919-25.
207. Kilkkinen A, Pietinen P, Klaukka T, Virtamo J, Korhonen P, Adlercreutz H. Use of oral antimicrobials decreases serum enterolactone concentration. American Journal of Epidemiology 2002;155(5):472-7.
208. Kristo A, Uhari M. Timing of rhinosinusitis complications in children. Pediatric Infectious Disease Journal 2009;28(9):769-71.
209. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngology -Head and Neck Surgery 1997;117(Suppl):1-7.
210. Lawson W, Patel ZM, Lin FY. The development and pathologic processes that influence maxillary sinus pneumatization. Anatomical Record (Hoboken) 2008;291(11):1554-63.
211. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org. 5.1. Chichester, UK: Wiley-Blackwell, 2011.
212. Lemiengre MB, van Driel ML, Merenstein D, Young J, de Sutter AIM. Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD006089.pub4]
213. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-70.
214. Linder JA, Singer DE, van den Ancker M, Atlas SJ. Measures of health-related quality of life for adults with acute sinusitis. Journal of General Internal Medicine 2003;18:390-401.
215. Low DE, Desrosiers M, McSherry J, Garber G, Williams JW Jr, Remy H, et al.A practical guide for the diagnosis and treatment of acute sinusitis. Canadian Medical Association Journal 1997;156(Suppl 6):1-14.
216. Margolis DJ, Bowe WP, Hoffstad O, Berlin JA. Antibiotic treatment of acne may be associated with upper respiratory tract infections. Archives of Dermatology 2005;141(9):1132-6.
217. Maxwell PR, Rink E, Kumar D, Mendall MA. Antibiotics increase functional abdominal symptoms. American Journal of Gastroenterology 2002;97(1):104-8.
218. Meltzer E, Hamilos D, Hadley J, Lanza D, Marple B, Nicklas R, et al.Rhinosinusitis: establishing definitions for clinical research and patient care. Journal of Allergy and Clinical Immunology 2004;114(Suppl):155-212.
219. Meltzer E, Hamilos D, Hadley J, Lanza D, Marple B, Nicklas R, et al.Rhinosinusitis: developing guidance for clinical trials. Otolaryngology -Head and Neck Surgery 2006;135(Suppl):31-80.
220. Odenholt I, Gustafsson I, Löwdin E, Cars O. Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: in vitro kinetic model. Antimicrobial Agents and Chemotherapy 2003;47(2):518-23.
221. Puhakka T, Mäkelä MJ, Alanen A, Kallio T, Korsoff L, Arstila P, et al.Sinusitis in the common cold. Journal of Allergy and Clinical Immunology 1998;102(3):403-8.
222. Puhakka T, Heikkinen T, Mäkelä MJ, Alanen A, Kallio T, Korsoff L, et al.Validity of ultrasonography in diagnosis of acute maxillary sinusitis. Archives of Otolaryngology -Head and Neck Surgery 2000;126(12):1482-6.
223. Rautakorpi U-M, Lumio J, Huovinen P, Klaukka T. Indication-based use of antimicrobials in Finnish primary health care. Description of a method for data collection and results of its application. Scandinavian Journal of Primary Health Care 1999;17(2):93-9.
224. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
225. Rosenfeld RM, Singer M, Jones S. Systematic review of antimicrobial therapy in patients with acute rhinosinusitis. Otolaryngology -Head and Neck Surgery 2007;137(Suppl):32-45.
226. Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis 2004. Otolaryngology -Head and Neck Surgery 2004;130(Suppl 1):1-50.
227. Seppälä H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clinical Infectious Diseases 1995;21(6):1378-85.
228. Slavin RG, Spector SL, Bernstein IL, Sinusitis Update Workgroup. The diagnosis and management of sinusitis. A practice parameter update. Journal of Allergy and Clinical Immunology 2005;116(Suppl):13-47.
229. Smith HS, Hughes JP, Hooton TM, Roberts P, Scholes D, Stergachis A, et al.Antecedent antimicrobial use increases the risk of uncomplicated cystitis in young women. Clinical Infectious Diseases 1997;25(1):63-8.
230. Snow V, Mottur-Pilson C, Hickner JM. Principles of appropriate antibiotic use for acute sinusitis in adults. Annals of Internal Medicine 2001;134(6):495-7.
231. Stalman W, van Essen GA, van der Graaf Y, de Melker RA. Maxillary sinusitis in adults: an evaluation of placebo-controlled double-blind trials. Family Practice 1997;14(2):124-9.
232. Steinke D, Davey P. Association between antibiotic resistance and community prescribing: a critical review of bias and confounding in published studies. Clinical Infectious Diseases 2001;33(Suppl 3):193-205.
233. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org. Chichester, UK: Wiley-Blackwell, 2011.
234. Unnebrink K, Windeler J. Intention-to-treat: methods for dealing with missing values in clinical trials of progressively deteriorating diseases. Statistics in Medicine 2001;20:3931-46.
235. Varonen H, Savolainen S, Kunnamo I, Heikkinen R, Revonta M. Acute rhinosinusitis in primary care: a comparison of symptoms, signs, ultrasound, and radiography. Rhinology 2003;41(1):37-43.
236. Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. JAMA 2004;291(7):827-35.
237. Williams JW Jr, Simel DL. Does this patient have sinusitis?. JAMA 1993;270(10):1242-6.
238. Wu AW, Shapiro NL, Bhattacharyya N. Chronic rhinosinusitis in children: what are the treatment options?. Immunology and Allergy Clinics of North America 2009;29(4):705-17.
239. Young J, De Sutter A, Merenstein D, van Essen GA, Kaiser L, Varonen H, et al.Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data. Lancet 2008;371:908-14.
240. Ahovuo-Saloranta A, Borisenko OV, Kovanen N, Varonen H, Rautakorpi U-M, Williams Jr. JW, et al.Antibiotics for acute maxillary sinusitis. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD000243.pub2]
241. Ahovuo-Saloranta A, Rautakorpi U-M, Borisenko OV, Liira H, Williams Jr. JW, et al.Antibiotics for acute maxillary sinusitis. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD000243.pub2]
242. Williams Jr. JW, Aguilar C, Makela M, Cornell J, Hollman DR, Chiquette E, et al.Antimicrobial therapy for acute maxillary sinusitis. Cochrane Database of Systematic Reviews 1999, Issue 3. [DOI: 10.1002/14651858.CD000243.pub2]
243. Williams Jr. JW, Aguilar C, Cornell J, Chiquette E. Dolor RJ, Makela M, et al.Antibiotics for acute maxillary sinusitis. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD000243.pub2]